The initial promise of LLMs as a total fix for enterprise automation has stalled. We have solved for reasoning at scale, but turning that reasoning into real-world results is a different story. We ...

For decades, India’s governance failures were conveniently attributed to the absence of political will. That explanation no ...

Discover how Zero Knowledge Proof treats storage as a first-class citizen to build truly decentralized applications that ...

Training gets the hype, but inferencing is where AI actually works — and the choices you make there can make or break ...

Modern bot detection rarely deals with obviously fake browsers. Most large-scale automation today runs inside browser ...

AIFF has proposed a new governance model for the ISL. Here’s what changes, who controls key decisions, & why it matters for ...

Laughing Water Capital reported a 3.9% annual return, emphasizing fundamental growth in core holdings despite a market ...

A staggering 87% of enterprises missed 2025 revenue targets despite record levels of AI investment, according to new research from Clari Labs, the data and AI research division of Clari + Salesloft.

Travere Therapeutics, Inc., announced that today the U.S. Food and Drug Administration (FDA) has extended the review timeline of its supplemental New Drug Application (sNDA) for FILSPARI® (sparsentan) ...